awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38150875-050B932A-FEEC-495F-914D-727FC3DF008C
Q38150875-050B932A-FEEC-495F-914D-727FC3DF008C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38150875-050B932A-FEEC-495F-914D-727FC3DF008C
Systemic therapies in hepatocellular carcinoma: present and future.
P2860
Q38150875-050B932A-FEEC-495F-914D-727FC3DF008C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38150875-050B932A-FEEC-495F-914D-727FC3DF008C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fe26cfa1f4e09be74ec5a86d2814f53f34ac72e2
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.